165 related articles for article (PubMed ID: 23643546)
21. Reverse remodeling of the failing ventricle: surgical intervention with the Acorn Cardiac Support Device.
Oz MC; Konertz WF; Raman J; Kleber FX
Congest Heart Fail; 2004; 10(2):96-104; discussion 105. PubMed ID: 15073455
[TBL] [Abstract][Full Text] [Related]
22. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction.
Blom AS; Mukherjee R; Pilla JJ; Lowry AS; Yarbrough WM; Mingoia JT; Hendrick JW; Stroud RE; McLean JE; Affuso J; Gorman RC; Gorman JH; Acker MA; Spinale FG
Circulation; 2005 Aug; 112(9):1274-83. PubMed ID: 16129812
[TBL] [Abstract][Full Text] [Related]
23. Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.
Rastogi S; Mishra S; Gupta RC; Sabbah HN
Heart Fail Rev; 2005 Jun; 10(2):157-63. PubMed ID: 16258723
[TBL] [Abstract][Full Text] [Related]
24. Mitral valve repair: What the ACORN Trial taught us.
Ali MW; Bolling SF
Curr Cardiol Rep; 2010 Mar; 12(2):116-21. PubMed ID: 20425165
[TBL] [Abstract][Full Text] [Related]
25. Passive ventricular constraint prevents transmural shear strain progression in left ventricle remodeling.
Cheng A; Nguyen TC; Malinowski M; Langer F; Liang D; Daughters GT; Ingels NB; Miller DC
Circulation; 2006 Jul; 114(1 Suppl):I79-86. PubMed ID: 16820650
[TBL] [Abstract][Full Text] [Related]
26. Effects of cardiac support device on reverse remodeling: molecular, biochemical, and structural mechanisms.
Sabbah HN
J Card Fail; 2004 Dec; 10(6 Suppl):S207-14. PubMed ID: 15803552
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial.
Mann DL; Kubo SH; Sabbah HN; Starling RC; Jessup M; Oh JK; Acker MA
J Thorac Cardiovasc Surg; 2012 May; 143(5):1036-42. PubMed ID: 21762937
[TBL] [Abstract][Full Text] [Related]
28. Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study.
Guccione JM; Salahieh A; Moonly SM; Kortsmit J; Wallace AW; Ratcliffe MB
Ann Thorac Surg; 2003 Oct; 76(4):1171-80; discussion 1180. PubMed ID: 14530007
[TBL] [Abstract][Full Text] [Related]
29. Early and late effects of passive epicardial constraint on left ventricular geometry: ellipsoidal re-shaping confirmed by electron-beam computed tomography.
Lembcke A; Dushe S; Dohmen PM; Hoffmann U; Wegner B; Kloeters C; Enzweiler CN; Hamm B; Konertz WF
J Heart Lung Transplant; 2006 Jan; 25(1):90-8. PubMed ID: 16399536
[TBL] [Abstract][Full Text] [Related]
30. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure.
Saavedra WF; Tunin RS; Paolocci N; Mishima T; Suzuki G; Emala CW; Chaudhry PA; Anagnostopoulos P; Gupta RC; Sabbah HN; Kass DA
J Am Coll Cardiol; 2002 Jun; 39(12):2069-76. PubMed ID: 12084610
[TBL] [Abstract][Full Text] [Related]
31. Residual Stress Impairs Pump Function After Surgical Ventricular Remodeling: A Finite Element Analysis.
Pantoja JL; Zhang Z; Tartibi M; Sun K; Macmillan W; Guccione JM; Ge L; Ratcliffe MB
Ann Thorac Surg; 2015 Dec; 100(6):2198-205. PubMed ID: 26341601
[TBL] [Abstract][Full Text] [Related]
32. Ventricular constraint in severe heart failure halts decline in cardiovascular function associated with experimental dilated cardiomyopathy.
Raman JS; Byrne MJ; Power JM; Alferness CA
Ann Thorac Surg; 2003 Jul; 76(1):141-7. PubMed ID: 12842528
[TBL] [Abstract][Full Text] [Related]
33. CardioClasp changes left ventricular shape acutely in enlarged canine heart.
Kashem A; Santamore WP; Hassan S; Melvin DB; Crabbe DL; Margulies KB; Goldman BI; Llort F; Krieger C; Lesniak J
J Card Surg; 2003; 18 Suppl 2():S49-60. PubMed ID: 12930271
[TBL] [Abstract][Full Text] [Related]
34. Midterm results of passive containment surgery using the acorn Cor Cap cardiac support device in dilated cardiomyopathy.
Bredin F; Franco-Cereceda A
J Card Surg; 2010; 25(1):107-12. PubMed ID: 19538229
[TBL] [Abstract][Full Text] [Related]
35. Left atrial reverse remodeling in dogs with moderate and advanced heart failure treated with a passive mechanical containment device: an echocardiographic study.
Zacà V; Brewer R; Khanal S; Imai M; Jiang A; Wang M; Goldstein S; Sabbah HN
J Card Fail; 2007 May; 13(4):312-7. PubMed ID: 17517352
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of the Acorn Cardiac Support Device in animals with heart failure secondary to high rate pacing.
Power JM; Raman J; Byrne MJ; Alferness CA
Heart Fail Rev; 2005 Jun; 10(2):117-23. PubMed ID: 16258719
[TBL] [Abstract][Full Text] [Related]
37. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial.
Acker MA; Bolling S; Shemin R; Kirklin J; Oh JK; Mann DL; Jessup M; Sabbah HN; Starling RC; Kubo SH;
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):568-77, 577.e1-4. PubMed ID: 16935112
[TBL] [Abstract][Full Text] [Related]
38. Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure.
Mann DL; Acker MA; Jessup M; Sabbah HN; Starling RC; Kubo SH;
J Card Fail; 2004 Jun; 10(3):185-92. PubMed ID: 15190527
[TBL] [Abstract][Full Text] [Related]
39. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
Sabbah HN; Sharov VG; Gupta RC; Mishra S; Rastogi S; Undrovinas AI; Chaudhry PA; Todor A; Mishima T; Tanhehco EJ; Suzuki G
Circ Res; 2003 Nov; 93(11):1095-101. PubMed ID: 14563716
[TBL] [Abstract][Full Text] [Related]
40. Device-based left ventricular geometry change for heart failure treatment: developmental work and current status.
Fukamachi K; Inoue M; Doi K; Schenk S; Nemeh H; Dessoffy R; Kopcak MW; McCarthy PM
J Card Surg; 2003; 18 Suppl 2():S43-7. PubMed ID: 12930270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
